As of April 2026, no FDA guidance formally distinguishing PDA from BPC-157 has been issued
Zheng X, Lin D, Zhang Y, et al
TB-500 provides critical enhancement of cellular migration and epithelial coverage that drives wound closure, with research demonstrating that topical or intraperitoneal TB-500 administration increases reepithelialization by 42% over controls at 4 days post-wounding and 61% at 7 days, with treated wounds showing enhanced contraction (at least 11% more than controls by day 7) and superior architectural organization
The visual and chemical tests that separate real GHK-Cu from fakes take less than five minutes to run and require no specialised equipment beyond household items you already own
[DOI] [PMC free article] [PubMed] [Google Scholar] 228.Mascitelli L., Goldstein M.R
Epitalon should only be used under the guidance of a doctor experienced in peptide protocols